CITY-OF-TAMPERE
17.9.2022 16:01:36 CEST | Business Wire | Press release
Sara Hildén Art Museum in Tampere Finland is proud to present Thomas Houseago’s first exhibition in the Nordic countries. Thomas Houseago is a world-renowned artist. In the Tampere exhibition, Houseago is presenting his own sculptures and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. Cave and Pitt are already renowned in their respective fields of music and cinema, but this is the first time ever they have exhibited their artwork pieces created during the course of an ongoing dialogue with Houseago.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005685/en/
Sara Hildén Art Museum in Tampere Finland presents Thomas Houseago’s first exhibition in the Nordic countries. Houseago is presenting his own sculpture and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. The Exhibition opened on 17th September 2022. Museum Director Anna Hjorth-Röntynen, Nick Cave, Chief Curator Sarianne Saikkonen, Thomas Houseago, Mayor of Tampere Anna-Kaisa Ikonen and Brad Pitt. Photo: Jussi Koivunen
“I’m very happy and proud that Thomas Houseago decided to bring WE to Tampere. It is also exciting to get to experience a new and different artistic side of Nick Cave and Brad Pitt. WE delivers a strong message of working together, creating something new and a sense of community that is compatible with Tampere, as the city is known for its capacity for change and making bold decisions together. The message of doing together and relying on each other is very powerful in these turbulent times”, says Anna-Kaisa Ikonen, Mayor of Tampere.
In addition to the WE-exhibition at Sara Hildén, Tampere’s autumn and winter of art is plentiful and bright. Tampere Art Museum offers rarities from Finnish art foundations commencing on Oct 8th. The exhibition includes works by artists such as Helene Schjerfbeck, Ellen Thesleff, Fanny Churberg, Akseli Gallen-Kallela and Tyko Sallinen. The other museums of Tampere, for example Vapriikki, offer experiences for the whole family. Especially the Moomin Museum is a favourite of kids.
The Tampere Philharmonic plays beloved classics and new pieces. The brand new Nokia Arena will host exciting international concerts. Tampere is also the theatre capital of Finland, and the theatres of Tampere are full of great musicals, drama, comedy and crime stories.
Tampere has direct flight routes to many European destinations, for example to Amsterdam, Oslo, Malaga, Riga and München. It is also easily reached from the Finnish capital Helsinki, for example, the train ride from Helsinki to Tampere takes about 1,5 hours.
Thomas Houseago – WE with Nick Cave & Brad Pitt 18.9.2022 – 15.1.2023 at Sara Hildén Art Museum.
www.sarahildenintaidemuseo.fi, www.tampere.fi/en/international-tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005685/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom